A magnifying glass. It indicates, "Click to perform a search". A magnifying glass. It indicates, "Click to perform a search". The word "Markets Insider". Enable Injections reinforces commitment to ...

The MarketWatch News Department was not involved in the creation of this content. Enable Injections Announces Agreement with Sobi(R) to Develop and Distribute Aspaveli(R) in Combination with enFuse(R) ...

CINCINNATI, May 22, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable"), a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery System (OBDS), today ...

The MarketWatch News Department was not involved in the creation of this content. CINCINNATI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable") a healthcare innovation company ...

Through this partnership, Aptar Digital Health will deliver a companion digital solution for Enable Injections’ enFuse® system designed to enhance the patient experience and support adherence-related ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Cincinnati’s top venture ...

CINCINNATI, May 22, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® wearable drug delivery platform today ...

EVENDALE, Ohio — One of Greater Cincinnati’s fastest-growing startups is planning to consolidate three locations into one $45 million headquarters capable of holding more than 1,000 employees. Enable ...

The commercial success of large-volume biologics hinges on overcoming the major challenges they pose: They are hard for patients to take, hard to make, and costly. But they become a marketer’s dream ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. It’s another round for the record books. Enable ...

Enable Injections, maker of manual and connected adhesive wearables for subcutaneously therapeutic delivery, has raised $50 million in a Series B round led by Sanofi, the company announced today. ORI ...